1. Home
  2. RFL vs WKHS Comparison

RFL vs WKHS Comparison

Compare RFL & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • WKHS
  • Stock Information
  • Founded
  • RFL 2017
  • WKHS 2007
  • Country
  • RFL United States
  • WKHS United States
  • Employees
  • RFL N/A
  • WKHS N/A
  • Industry
  • RFL Real Estate
  • WKHS Auto Manufacturing
  • Sector
  • RFL Finance
  • WKHS Consumer Discretionary
  • Exchange
  • RFL Nasdaq
  • WKHS Nasdaq
  • Market Cap
  • RFL 55.3M
  • WKHS 44.3M
  • IPO Year
  • RFL N/A
  • WKHS N/A
  • Fundamental
  • Price
  • RFL $1.84
  • WKHS $0.82
  • Analyst Decision
  • RFL
  • WKHS Sell
  • Analyst Count
  • RFL 0
  • WKHS 3
  • Target Price
  • RFL N/A
  • WKHS $5.75
  • AVG Volume (30 Days)
  • RFL 25.8K
  • WKHS 2.7M
  • Earning Date
  • RFL 12-27-2024
  • WKHS 11-19-2024
  • Dividend Yield
  • RFL N/A
  • WKHS N/A
  • EPS Growth
  • RFL N/A
  • WKHS N/A
  • EPS
  • RFL N/A
  • WKHS N/A
  • Revenue
  • RFL $697,000.00
  • WKHS $9,097,780.00
  • Revenue This Year
  • RFL N/A
  • WKHS N/A
  • Revenue Next Year
  • RFL N/A
  • WKHS $247.90
  • P/E Ratio
  • RFL N/A
  • WKHS N/A
  • Revenue Growth
  • RFL 151.62
  • WKHS N/A
  • 52 Week Low
  • RFL $1.29
  • WKHS $0.57
  • 52 Week High
  • RFL $2.50
  • WKHS $8.18
  • Technical
  • Relative Strength Index (RSI)
  • RFL 45.87
  • WKHS 38.91
  • Support Level
  • RFL $1.74
  • WKHS $0.99
  • Resistance Level
  • RFL $1.92
  • WKHS $1.26
  • Average True Range (ATR)
  • RFL 0.09
  • WKHS 0.09
  • MACD
  • RFL -0.00
  • WKHS -0.03
  • Stochastic Oscillator
  • RFL 40.91
  • WKHS 3.09

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

Share on Social Networks: